Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamran Aryana

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Clinical Nuclear Medicine|May 24, 2021
Prostate Cancer With Neuroendocrine Differentiation Recurring After Treatment With 177Lu-PSMA: A Chance for 177Lu-DOTATATE Therapy?Farnaz Nesari Javan, Kamran Aryana, Emran Askari
Clinical Nuclear Medicine|January 23, 2025
99m Tc-FAPI-46 Scan and 177 Lu-FAPI-2286 Treatment in a Patient With Nasopharyngeal CarcinomaSomaye Barashki, Bentolhoda Hadad, Nasrin Raeisi, et al.
Data in Brief|June 29, 2023
A dataset of [<sup>68</sup>Ga]Ga-Pentixafor PET/CT images of patients with high-grade GliomaHessamoddin Roustaei, Nasim Norouzbeigi, Habibeh Vosoughi, et al.
Clinical Nuclear Medicine|February 20, 2024
99m Tc-HYNIC-FAPI-46 SPECT/CT Uptake in Lactating BreastsBentolhoda Hadad, Kamran Aryana, Hassan Kamali, et al.
Clinical Nuclear Medicine|February 6, 2018
177Lu-Prostate-Specific Membrane Antigen Super Scan and Good Response Even After 1 Cycle of Radioligand TherapyKamran Aryana, Soroush Zarehparvar Moghadam, Roham Salek, et al.
Clinical Nuclear Medicine|July 6, 2019
Favorable Response After Only One Cycle of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Metastatic Merkel Cell CarcinomaSoroush Zarehparvar Moghadam, Ghasemali Divband, Sara Shakeri, et al.
Clinical Nuclear Medicine|July 1, 2020
Whole-Body 177Lu-Prostate-Specific Membrane Antigen Scan Pattern With Excess Free 177Lu-Chloride in a Metastatic Castration-Resistant Prostate Cancer PatientEmran Askari, Soroush Zarehparvar Moghadam, Ghasemali Divband, et al.
Clinical Nuclear Medicine|December 8, 2025
99mTc-FAPI Scintigraphy in Metastasis Workup of Sinonasal Rhabdomyosarcoma; Unveiling Diffuse Bone Marrow InvolvementNasrin Raeisi, Amin Saber Tanha, Hassan Kamali, et al.
Clinical Nuclear Medicine|April 17, 2025
Combination Therapy With 177Lu-FAPI-2286 and Tyrosine Kinase Inhibitor: A Novel Approach for Treating Metastatic Medullary Thyroid CarcinomaNasrin Raeisi, Amin Saber Tanha, Sajad Ataei Azimi, et al.
Nuklearmedizin. Nuclear Medicine|June 27, 2019
Application of 99mTc-UBI 29-41 scintigraphy in knee periprosthetic infection diagnosisZahra Kiamanesh, Narjess Ayati, Royasadat Alavi, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Clinical Nuclear Medicine|May 24, 2021
Prostate Cancer With Neuroendocrine Differentiation Recurring After Treatment With 177Lu-PSMA: A Chance for 177Lu-DOTATATE Therapy?Farnaz Nesari Javan, Kamran Aryana, Emran Askari
Clinical Nuclear Medicine|January 23, 2025
99m Tc-FAPI-46 Scan and 177 Lu-FAPI-2286 Treatment in a Patient With Nasopharyngeal CarcinomaSomaye Barashki, Bentolhoda Hadad, Nasrin Raeisi, et al.
Data in Brief|June 29, 2023
A dataset of [<sup>68</sup>Ga]Ga-Pentixafor PET/CT images of patients with high-grade GliomaHessamoddin Roustaei, Nasim Norouzbeigi, Habibeh Vosoughi, et al.
Clinical Nuclear Medicine|February 20, 2024
99m Tc-HYNIC-FAPI-46 SPECT/CT Uptake in Lactating BreastsBentolhoda Hadad, Kamran Aryana, Hassan Kamali, et al.
Clinical Nuclear Medicine|February 6, 2018
177Lu-Prostate-Specific Membrane Antigen Super Scan and Good Response Even After 1 Cycle of Radioligand TherapyKamran Aryana, Soroush Zarehparvar Moghadam, Roham Salek, et al.
Clinical Nuclear Medicine|July 6, 2019
Favorable Response After Only One Cycle of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Metastatic Merkel Cell CarcinomaSoroush Zarehparvar Moghadam, Ghasemali Divband, Sara Shakeri, et al.
Clinical Nuclear Medicine|July 1, 2020
Whole-Body 177Lu-Prostate-Specific Membrane Antigen Scan Pattern With Excess Free 177Lu-Chloride in a Metastatic Castration-Resistant Prostate Cancer PatientEmran Askari, Soroush Zarehparvar Moghadam, Ghasemali Divband, et al.
Clinical Nuclear Medicine|December 8, 2025
99mTc-FAPI Scintigraphy in Metastasis Workup of Sinonasal Rhabdomyosarcoma; Unveiling Diffuse Bone Marrow InvolvementNasrin Raeisi, Amin Saber Tanha, Hassan Kamali, et al.
Clinical Nuclear Medicine|April 17, 2025
Combination Therapy With 177Lu-FAPI-2286 and Tyrosine Kinase Inhibitor: A Novel Approach for Treating Metastatic Medullary Thyroid CarcinomaNasrin Raeisi, Amin Saber Tanha, Sajad Ataei Azimi, et al.
Nuklearmedizin. Nuclear Medicine|June 27, 2019
Application of 99mTc-UBI 29-41 scintigraphy in knee periprosthetic infection diagnosisZahra Kiamanesh, Narjess Ayati, Royasadat Alavi, et al.
Pageof 8